We will have ASHBi Seminar with Dr. So Miyoshi and Mr. Yamato Sano from Pfizer R&D Japan, on Tuesday, October 15.
For more details of the seminar, please check the flyer.
If you have any interest in the topic, you are welcome to attend this seminar.
---------------------------
この度、ファイザーR&D合同会社の三好 聡 氏と佐野 大和 氏をお招きし、2024年10月15日にASHBi Seminarを開催します。
講演内容の詳細は、ポスターをご覧ください。
ご興味のある方は是非ご参加ください。
開催日
-
2024/10/15
14:00–15:30
開催場所(方法)
Conference Room (B1F, Faculty of Medicine Bldg. B) /医学部B棟地下大会議室
* On-site participation will be closed when a capacity of 40 is reached.
* 会場参加については先着順とし、定員 (40名)になり次第、締め切ります。
詳細
[Contents]
14:00–14:30 So Miyoshi Ph.D. | Head of Clinical Pharmacology & Bioanalytics, Pfizer R&D Japan
“Current and Future Perspective of Model-Informed Drug Discovery and Development”
(数理モデルによる医薬品研究開発のパラダイムシフト)
14:30–15:00 Yamato Sano | Clinical Pharmacology Lead, Pfizer R&D Japan
“Advancing Quantitative Systems Pharmacology Model for Inflammatory Bowel Disease for Clinical Efficacy Predictions in Ulcerative Colitis"
15:00–15:30 Free Discussion
[note] Language| Japanese(1st talk) and English(2nd talk)
申し込み
要申し込み
Registration| https://forms.gle/xSmFVJ86KHN1CZhG9
* On-site participation will be closed when a capacity of 40 is reached.
* 会場参加については先着順とし、定員 (40名)になり次第、締め切ります。
参加費
Free / 無料
お問い合わせ
ashbi-event[at]mail2.adm.kyoto-u.ac.jp
* Please change [at] to @.